COMMUNIQUÉS West-GlobeNewswire

Immunovaccine Announces Leading Independent Proxy Advisory Firms Recommend Voting for Share Consolidation Related to Potential Nasdaq Listing

17/04/2018 - 13:05

HALIFAX, Nova Scotia, April 17, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, is pleased to announce that Institutional Shareholder Services Inc. (“ [...]

Myriad to Announce Fiscal Third-Quarter 2018 Financial Results on May 8, 2018

17/04/2018 - 13:05

Earnings Presentation Will Include GeneSight® Randomized Controlled Trial Results SALT LAKE CITY, April 17, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and [...]

Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal Products

17/04/2018 - 13:04

PETALUMA, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]

Orphazyme announces establishment of US subsidiary in Massachusetts

17/04/2018 - 13:00

Orphazyme A/S Investor news No. 06/2018 Copenhagen, April 17, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced the creation of [...]

Idera Pharmaceuticals Presents Pre-Clinical Data Demonstrating Potential for Tilsotolimod (IMO-2125) in Combination with Checkpoint Inhibitors at the American Association for Cancer Research (AACR) 2018 Annual Meeting

17/04/2018 - 13:00

Triple combination of tilsotolimod (IMO-2125), epacadostat (IDO-1) and anti-PD-1 antibody demonstrate maximal anti-tumor efficacy in pre-clinical models CHICAGO, April 17, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals [...]

Dr. Richard W. Hudspeth Joins Carolina Complete Health Networks’ Board of Directors

17/04/2018 - 13:00

RALEIGH, N.C., April 17, 2018 (GLOBE NEWSWIRE) -- Carolina Complete Health Network, Inc. (CCHN), a company formed to build and support a patient-focused, physician-led Medicaid health network, welcomes Richard W. [...]

Clinical Laserthermia Systems and Toronto General Hospital Begin Clinical Study for MRI-Guided Laser Ablation Treatment of Prostate Cancer

17/04/2018 - 13:00

FRAMINGHAM, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS Americas) a subsidiary of CLS AB in Lund, Sweden, today announced the commencement of a clinical study with [...]

CellAegis Strengthens Management Team to Support Future Growth

17/04/2018 - 13:00

TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for [...]

BeyondSpring Presents Lead Asset’s Mechanism Data for Prevention of Chemotherapy-Induced Neutropenia

17/04/2018 - 13:00

NEW YORK, April 17, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced the [...]

MPX Signs a Letter of Intent to Acquire Canadian Licenced Producer Canveda

17/04/2018 - 13:00

TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has signed a letter of intent (the “ LOI ”) to acquire 100% of [...]

Emerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based Products into Canadian Grocery, Natural Health Product, and Pharmacy Stores

17/04/2018 - 13:00

New joint venture, Emerald Health Naturals, secures exclusive Canadian rights to sell proprietary non-cannabis health products that support the human endocannabinoid system Initiative leverages natural health product [...]

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018

17/04/2018 - 12:48

Company Announcement Net sales of DARZALEX in the first quarter of 2018 totaled USD 432 million Genmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen, Denmark; April 17, 2018 – Genmab A/ [...]

Renaissance BioScience Corp. partners with Mitacs for $1.44-million project to advance its next-generation yeast development platform, tools and methods

17/04/2018 - 12:00

VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp. (RBSC), a leading global yeast technology company, is pleased to announce a new partnership with Mitacs for a multi-year, $1. [...]

Emerald Health Therapeutics Expands Strategic Investment in VANC

17/04/2018 - 10:00

VANC executes supply and distribution agreement with Emerald VANC issues warrants to Emerald VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” ) announced today that it [...]

LIDDS: Kallelse till årsstämma i LIDDS AB (publ)

17/04/2018 - 08:31

Aktieägarna i LIDDS AB (publ), org.nr. 556580-2856, kallas till årsstämma på Virdings allé 32B i Uppsala onsdagen den 16 maj 2018 kl. 15:00. Rätt att delta och anmälan Rätt att delta i bolagsstämman har den aktieägare [...]

Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi's European generics business

17/04/2018 - 08:31

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi's European generics business Advent to invest in Zentiva to create a new, [...]

Advent International entre en négociations exclusives pour acquérir Zentiva, l'activité Génériques de Sanofi en Europe

17/04/2018 - 08:31

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Advent International entre en négociations exclusives pour acquérir Zentiva, l'activité Génériques de Sanofi en Europe Advent va investir dans Zentiva [...]

CellaVision AB: The Nomination Committee of CellaVision AB supplements its proposal with an additional Board member

17/04/2018 - 08:21

The information was submitted to the public on April 17, 2018 at 8:20 CET The Nomination Committee presented its proposal to the Annual General Meeting on 4 May 2018 on April 4, 2018. The proposal and the motivated [...]

Posting of UK Annual Report and Accounts & Notice of AGM

17/04/2018 - 08:00

NEW YORK, April 17, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that its 2017 UK Annual [...]